-
2
-
-
0035572863
-
Epidemiology and molecular pathology of gallbladder cancer
-
Lazcano-Ponce EC, Miquel JF, Munoz N, Herrero R, Ferrecio C, Wistuba II, et al. Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin. 2001;51:349-64.
-
(2001)
CA Cancer J Clin
, vol.51
, pp. 349-364
-
-
Lazcano-Ponce, E.C.1
Miquel, J.F.2
Munoz, N.3
Herrero, R.4
Ferrecio, C.5
Wistuba, I.I.6
-
5
-
-
84880318852
-
Potential therapeutic targets for the primary gallbladder carcinoma: estrogen receptors
-
Zhang LQ, Zhang XD, Xu J, Wan Y, Qu K, Zhang JY, et al. Potential therapeutic targets for the primary gallbladder carcinoma: estrogen receptors. Asian Pac J Cancer Prev. 2013;14:2185-90.
-
(2013)
Asian Pac J Cancer Prev
, vol.14
, pp. 2185-2190
-
-
Zhang, L.Q.1
Zhang, X.D.2
Xu, J.3
Wan, Y.4
Qu, K.5
Zhang, J.Y.6
-
6
-
-
84895538497
-
Hedgehog signaling pathway is a potential therapeutic target for gallbladder cancer
-
Matsushita S, Onishi H, Nakano K, Nagamatsu I, Imaizumi A, Hattori M, et al. Hedgehog signaling pathway is a potential therapeutic target for gallbladder cancer. Cancer Sci. 2014;105:272-80.
-
(2014)
Cancer Sci
, vol.105
, pp. 272-280
-
-
Matsushita, S.1
Onishi, H.2
Nakano, K.3
Nagamatsu, I.4
Imaizumi, A.5
Hattori, M.6
-
7
-
-
84885236367
-
AKT/mTOR substrate P70S6K is frequently phosphorylated in gallbladder cancer tissue and cell lines
-
Leal P, Garcia P, Sandoval A, Buchegger K, Weber H, Tapia O, et al. AKT/mTOR substrate P70S6K is frequently phosphorylated in gallbladder cancer tissue and cell lines. Onco Targets Ther. 2013;6:1373-84.
-
(2013)
Onco Targets Ther
, vol.6
, pp. 1373-1384
-
-
Leal, P.1
Garcia, P.2
Sandoval, A.3
Buchegger, K.4
Weber, H.5
Tapia, O.6
-
8
-
-
80052855504
-
Quantitative tissue proteomics of esophageal squamous cell carcinoma for novel biomarker discovery
-
Pawar H, Kashyap MK, Sahasrabuddhe NA, Renuse S, Harsha HC, Kumar P, et al. Quantitative tissue proteomics of esophageal squamous cell carcinoma for novel biomarker discovery. Cancer Biol Ther. 2011;12:510-22.
-
(2011)
Cancer Biol Ther
, vol.12
, pp. 510-522
-
-
Pawar, H.1
Kashyap, M.K.2
Sahasrabuddhe, N.A.3
Renuse, S.4
Harsha, H.C.5
Kumar, P.6
-
9
-
-
55949092635
-
A quantitative proteomic approach for identification of potential biomarkers in hepatocellular carcinoma
-
Chaerkady R, Harsha HC, Nalli A, Gucek M, Vivekanandan P, Akhtar J, et al. A quantitative proteomic approach for identification of potential biomarkers in hepatocellular carcinoma. J Proteome Res. 2008;7:4289-98.
-
(2008)
J Proteome Res
, vol.7
, pp. 4289-4298
-
-
Chaerkady, R.1
Harsha, H.C.2
Nalli, A.3
Gucek, M.4
Vivekanandan, P.5
Akhtar, J.6
-
10
-
-
84921313925
-
Silencing of high-mobility group box 2 (HMGB2) modulates cisplatin and 5-fluorouracil sensitivity in head and neck squamous cell carcinoma
-
Syed N, Chavan S, Sahasrabuddhe NA, Renuse S, Sathe G, Nanjappa V, et al. Silencing of high-mobility group box 2 (HMGB2) modulates cisplatin and 5-fluorouracil sensitivity in head and neck squamous cell carcinoma. Proteomics. 2015;15:383-93.
-
(2015)
Proteomics
, vol.15
, pp. 383-393
-
-
Syed, N.1
Chavan, S.2
Sahasrabuddhe, N.A.3
Renuse, S.4
Sathe, G.5
Nanjappa, V.6
-
11
-
-
84873154142
-
Different expression of S100A8 in malignant and benign gallbladder diseases
-
Wang W, Ai KX, Yuan Z, Huang XY, Zhang HZ. Different expression of S100A8 in malignant and benign gallbladder diseases. Dig Dis Sci. 2013;58:150-62.
-
(2013)
Dig Dis Sci
, vol.58
, pp. 150-162
-
-
Wang, W.1
Ai, K.X.2
Yuan, Z.3
Huang, X.Y.4
Zhang, H.Z.5
-
12
-
-
79960764480
-
Proteomic-based analysis for identification of potential serum biomarkers in gallbladder cancer
-
Tan Y, Ma SY, Wang FQ, Meng HP, Mei C, Liu A, et al. Proteomic-based analysis for identification of potential serum biomarkers in gallbladder cancer. Oncol Rep. 2011;26:853-9.
-
(2011)
Oncol Rep
, vol.26
, pp. 853-859
-
-
Tan, Y.1
Ma, S.Y.2
Wang, F.Q.3
Meng, H.P.4
Mei, C.5
Liu, A.6
-
13
-
-
67349125420
-
Identification of metastasis-associated proteins involved in gallbladder carcinoma metastasis by proteomic analysis and functional exploration of chloride intracellular channel 1
-
Wang JW, Peng SY, Li JT, Wang Y, Zhang ZP, Cheng Y, et al. Identification of metastasis-associated proteins involved in gallbladder carcinoma metastasis by proteomic analysis and functional exploration of chloride intracellular channel 1. Cancer Lett. 2009;281:71-81.
-
(2009)
Cancer Lett
, vol.281
, pp. 71-81
-
-
Wang, J.W.1
Peng, S.Y.2
Li, J.T.3
Wang, Y.4
Zhang, Z.P.5
Cheng, Y.6
-
14
-
-
84862929921
-
Vimentin significantly promoted gallbladder carcinoma metastasis
-
Dong P, He XW, Gu J, Wu WG, Li ML, Yang JH, et al. Vimentin significantly promoted gallbladder carcinoma metastasis. Chin Med J (Engl). 2011;124:4236-44.
-
(2011)
Chin Med J (Engl)
, vol.124
, pp. 4236-4244
-
-
Dong, P.1
He, X.W.2
Gu, J.3
Wu, W.G.4
Li, M.L.5
Yang, J.H.6
-
15
-
-
0142259734
-
Macrophage migration inhibitory factor: a regulator of innate immunity
-
Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol. 2003;3:791-800.
-
(2003)
Nat Rev Immunol
, vol.3
, pp. 791-800
-
-
Calandra, T.1
Roger, T.2
-
16
-
-
33646820643
-
Increased epithelial and serum expression of macrophage migration inhibitory factor (MIF) in gastric cancer: potential role of MIF in gastric carcinogenesis
-
He XX, Yang J, Ding YW, Liu W, Shen QY, Xia HH. Increased epithelial and serum expression of macrophage migration inhibitory factor (MIF) in gastric cancer: potential role of MIF in gastric carcinogenesis. Gut. 2006;55:797-802.
-
(2006)
Gut
, vol.55
, pp. 797-802
-
-
He, X.X.1
Yang, J.2
Ding, Y.W.3
Liu, W.4
Shen, Q.Y.5
Xia, H.H.6
-
17
-
-
84879670277
-
Pharmacological inhibition of macrophage migration inhibitory factor interferes with the proliferation and invasiveness of squamous carcinoma cells
-
Kindt N, Laurent G, Nonclercq D, Journe F, Ghanem G, Duvillier H, et al. Pharmacological inhibition of macrophage migration inhibitory factor interferes with the proliferation and invasiveness of squamous carcinoma cells. Int J Oncol. 2013;43:185-93.
-
(2013)
Int J Oncol
, vol.43
, pp. 185-193
-
-
Kindt, N.1
Laurent, G.2
Nonclercq, D.3
Journe, F.4
Ghanem, G.5
Duvillier, H.6
-
18
-
-
84874745141
-
The expressions of MIF and CXCR4 protein in tumor microenvironment are adverse prognostic factors in patients with esophageal squamous cell carcinoma
-
Zhang L, Ye SB, Ma G, Tang XF, Chen SP, He J, et al. The expressions of MIF and CXCR4 protein in tumor microenvironment are adverse prognostic factors in patients with esophageal squamous cell carcinoma. J Transl Med. 2013;11:60.
-
(2013)
J Transl Med
, vol.11
, pp. 60
-
-
Zhang, L.1
Ye, S.B.2
Ma, G.3
Tang, X.F.4
Chen, S.P.5
He, J.6
-
19
-
-
59649119604
-
Macrophage migration inhibitory factor promotes colorectal cancer
-
He XX, Chen K, Yang J, Li XY, Gan HY, Liu CY, et al. Macrophage migration inhibitory factor promotes colorectal cancer. Mol Med. 2009;15:1-10.
-
(2009)
Mol Med
, vol.15
, pp. 1-10
-
-
He, X.X.1
Chen, K.2
Yang, J.3
Li, X.Y.4
Gan, H.Y.5
Liu, C.Y.6
-
20
-
-
84871364500
-
Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma
-
Funamizu N, Hu C, Lacy C, Schetter A, Zhang G, He P, et al. Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma. Int J Cancer. 2013;132:785-94.
-
(2013)
Int J Cancer
, vol.132
, pp. 785-794
-
-
Funamizu, N.1
Hu, C.2
Lacy, C.3
Schetter, A.4
Zhang, G.5
He, P.6
-
21
-
-
34447319652
-
Ovarian cancer cell-derived migration inhibitory factor enhances tumor growth, progression, and angiogenesis
-
Hagemann T, Robinson SC, Thompson RG, Charles K, Kulbe H, Balkwill FR. Ovarian cancer cell-derived migration inhibitory factor enhances tumor growth, progression, and angiogenesis. Mol Cancer Ther. 2007;6:1993-2002.
-
(2007)
Mol Cancer Ther
, vol.6
, pp. 1993-2002
-
-
Hagemann, T.1
Robinson, S.C.2
Thompson, R.G.3
Charles, K.4
Kulbe, H.5
Balkwill, F.R.6
-
22
-
-
36949019571
-
Macrophage migration inhibitory factor (MIF) gene polymorphisms are associated with increased prostate cancer incidence
-
Meyer-Siegler KL, Vera PL, Iczkowski KA, Bifulco C, Lee A, Gregersen PK, et al. Macrophage migration inhibitory factor (MIF) gene polymorphisms are associated with increased prostate cancer incidence. Genes Immun. 2007;8:646-52.
-
(2007)
Genes Immun
, vol.8
, pp. 646-652
-
-
Meyer-Siegler, K.L.1
Vera, P.L.2
Iczkowski, K.A.3
Bifulco, C.4
Lee, A.5
Gregersen, P.K.6
-
23
-
-
54749101549
-
A novel, macrophage migration inhibitory factor suicide substrate inhibits motility and growth of lung cancer cells
-
Winner M, Meier J, Zierow S, Rendon BE, Crichlow GV, Riggs R, et al. A novel, macrophage migration inhibitory factor suicide substrate inhibits motility and growth of lung cancer cells. Cancer Res. 2008;68:7253-7.
-
(2008)
Cancer Res
, vol.68
, pp. 7253-7257
-
-
Winner, M.1
Meier, J.2
Zierow, S.3
Rendon, B.E.4
Crichlow, G.V.5
Riggs, R.6
-
24
-
-
0022186670
-
Measurement of protein using bicinchoninic acid
-
Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, et al. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985;150:76-85.
-
(1985)
Anal Biochem
, vol.150
, pp. 76-85
-
-
Smith, P.K.1
Krohn, R.I.2
Hermanson, G.T.3
Mallia, A.K.4
Gartner, F.H.5
Provenzano, M.D.6
-
25
-
-
65249167537
-
Temporal analysis of neural differentiation using quantitative proteomics
-
Chaerkady R, Kerr CL, Marimuthu A, Kelkar DS, Kashyap MK, Gucek M, et al. Temporal analysis of neural differentiation using quantitative proteomics. J Proteome Res. 2009;8:1315-26.
-
(2009)
J Proteome Res
, vol.8
, pp. 1315-1326
-
-
Chaerkady, R.1
Kerr, C.L.2
Marimuthu, A.3
Kelkar, D.S.4
Kashyap, M.K.5
Gucek, M.6
-
26
-
-
29244448703
-
Parts per million mass accuracy on an Orbitrap mass spectrometer via lock mass injection into a C-trap
-
Olsen JV, de Godoy LM, Li G, Macek B, Mortensen P, Pesch R, et al. Parts per million mass accuracy on an Orbitrap mass spectrometer via lock mass injection into a C-trap. Mol Cell Proteomics. 2005;4:2010-21.
-
(2005)
Mol Cell Proteomics
, vol.4
, pp. 2010-2021
-
-
Olsen, J.V.1
Godoy, L.M.2
Li, G.3
Macek, B.4
Mortensen, P.5
Pesch, R.6
-
27
-
-
84855658379
-
Human Protein Reference Database and Human Proteinpedia as resources for phosphoproteome analysis
-
Goel R, Harsha HC, Pandey A, Prasad TSK. Human Protein Reference Database and Human Proteinpedia as resources for phosphoproteome analysis. Mol Biosyst. 2012;8:453-63.
-
(2012)
Mol Biosyst
, vol.8
, pp. 453-463
-
-
Goel, R.1
Harsha, H.C.2
Pandey, A.3
Prasad, T.S.K.4
-
28
-
-
84883325315
-
Access guide to human proteinpedia
-
Baxevanis AD, editor. Current Protocols in Bioinformatics. Chapter 1
-
Muthusamy B, Thomas JK, Prasad TSK, Pandey A. Access guide to human proteinpedia. In: Baxevanis AD, editor. Current Protocols in Bioinformatics, vol. Chapter 1. 2013. p. Unit 1 21.
-
(2013)
, pp. 21
-
-
Muthusamy, B.1
Thomas, J.K.2
Prasad, T.S.K.3
Pandey, A.4
-
29
-
-
58149202157
-
Human Proteinpedia: a unified discovery resource for proteomics research
-
Kandasamy K, Keerthikumar S, Goel R, Mathivanan S, Patankar N, Shafreen B, et al. Human Proteinpedia: a unified discovery resource for proteomics research. Nucleic Acids Res. 2009;37:D773-781.
-
(2009)
Nucleic Acids Res
, vol.37
, pp. D773-781
-
-
Kandasamy, K.1
Keerthikumar, S.2
Goel, R.3
Mathivanan, S.4
Patankar, N.5
Shafreen, B.6
-
30
-
-
84874762979
-
The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013
-
Vizcaino JA, Cote RG, Csordas A, Dianes JA, Fabregat A, Foster JM, et al. The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013. Nucleic Acids Res. 2013;41:D1063-1069.
-
(2013)
Nucleic Acids Res
, vol.41
, pp. D1063-1069
-
-
Vizcaino, J.A.1
Cote, R.G.2
Csordas, A.3
Dianes, J.A.4
Fabregat, A.5
Foster, J.M.6
-
31
-
-
84899471783
-
Identification of prosaposin and transgelin as potential biomarkers for gallbladder cancer using quantitative proteomics
-
Sahasrabuddhe NA, Barbhuiya MA, Bhunia S, Subbannayya T, Gowda H, Advani J, et al. Identification of prosaposin and transgelin as potential biomarkers for gallbladder cancer using quantitative proteomics. Biochem Biophys Res Commun. 2014;446:863-9.
-
(2014)
Biochem Biophys Res Commun
, vol.446
, pp. 863-869
-
-
Sahasrabuddhe, N.A.1
Barbhuiya, M.A.2
Bhunia, S.3
Subbannayya, T.4
Gowda, H.5
Advani, J.6
-
32
-
-
79958787979
-
Adenylate kinase 3 sensitizes cells to cigarette smoke condensate vapor induced cisplatin resistance
-
Chang X, Ravi R, Pham V, Bedi A, Chatterjee A, Sidransky D. Adenylate kinase 3 sensitizes cells to cigarette smoke condensate vapor induced cisplatin resistance. PLoS One. 2011;6, e20806.
-
(2011)
PLoS One
, vol.6
-
-
Chang, X.1
Ravi, R.2
Pham, V.3
Bedi, A.4
Chatterjee, A.5
Sidransky, D.6
-
33
-
-
33750742792
-
Targeting of mutant hogg1 in mammalian mitochondria and nucleus: effect on cellular survival upon oxidative stress
-
Chatterjee A, Mambo E, Zhang Y, Deweese T, Sidransky D. Targeting of mutant hogg1 in mammalian mitochondria and nucleus: effect on cellular survival upon oxidative stress. BMC cancer. 2006;6:235.
-
(2006)
BMC cancer
, vol.6
, pp. 235
-
-
Chatterjee, A.1
Mambo, E.2
Zhang, Y.3
Deweese, T.4
Sidransky, D.5
-
34
-
-
0033965121
-
Cd44: a marker of squamous differentiation in adenosquamous neoplasms
-
Ylagan LR, Scholes J, Demopoulos R. Cd44: a marker of squamous differentiation in adenosquamous neoplasms. Arch Pathol Lab Med. 2000;124:212-5.
-
(2000)
Arch Pathol Lab Med
, vol.124
, pp. 212-215
-
-
Ylagan, L.R.1
Scholes, J.2
Demopoulos, R.3
-
35
-
-
80052506042
-
Correlation between MMP1-PAR1 axis and clinical outcome of primary gallbladder carcinoma
-
Du X, Wang S, Lu J, Cao Y, Song N, Yang T, et al. Correlation between MMP1-PAR1 axis and clinical outcome of primary gallbladder carcinoma. Jpn J Clin Oncol. 2011;41:1086-93.
-
(2011)
Jpn J Clin Oncol
, vol.41
, pp. 1086-1093
-
-
Du, X.1
Wang, S.2
Lu, J.3
Cao, Y.4
Song, N.5
Yang, T.6
-
36
-
-
34247120155
-
Frequent occurrence of abnormal E-cadherin/beta-catenin protein expression in advanced gallbladder cancers and its association with decreased apoptosis
-
Hirata K, Ajiki T, Okazaki T, Horiuchi H, Fujita T, Kuroda Y. Frequent occurrence of abnormal E-cadherin/beta-catenin protein expression in advanced gallbladder cancers and its association with decreased apoptosis. Oncology. 2006;71:102-10.
-
(2006)
Oncology
, vol.71
, pp. 102-110
-
-
Hirata, K.1
Ajiki, T.2
Okazaki, T.3
Horiuchi, H.4
Fujita, T.5
Kuroda, Y.6
-
37
-
-
0037414795
-
Adhesion-dependent signaling by macrophage migration inhibitory factor (MIF)
-
Liao H, Bucala R, Mitchell RA. Adhesion-dependent signaling by macrophage migration inhibitory factor (MIF). J Biol Chem. 2003;278:76-81.
-
(2003)
J Biol Chem
, vol.278
, pp. 76-81
-
-
Liao, H.1
Bucala, R.2
Mitchell, R.A.3
-
38
-
-
27744530222
-
ISO-1 binding to the tautomerase active site of MIF inhibits its pro-inflammatory activity and increases survival in severe sepsis
-
Al-Abed Y, Dabideen D, Aljabari B, Valster A, Messmer D, Ochani M, et al. ISO-1 binding to the tautomerase active site of MIF inhibits its pro-inflammatory activity and increases survival in severe sepsis. J Biol Chem. 2005;280:36541-4.
-
(2005)
J Biol Chem
, vol.280
, pp. 36541-36544
-
-
Al-Abed, Y.1
Dabideen, D.2
Aljabari, B.3
Valster, A.4
Messmer, D.5
Ochani, M.6
-
39
-
-
84872598312
-
Cancer-related inflammation
-
Candido J, Hagemann T. Cancer-related inflammation. J Clin Immunol. 2013;33 Suppl 1:S79-84.
-
(2013)
J Clin Immunol
, vol.33
, pp. S79-84
-
-
Candido, J.1
Hagemann, T.2
-
40
-
-
34249066942
-
MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment
-
Bernhagen J, Krohn R, Lue H, Gregory JL, Zernecke A, Koenen RR, et al. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med. 2007;13:587-96.
-
(2007)
Nat Med
, vol.13
, pp. 587-596
-
-
Bernhagen, J.1
Krohn, R.2
Lue, H.3
Gregory, J.L.4
Zernecke, A.5
Koenen, R.R.6
-
41
-
-
0033571182
-
A proinflammatory cytokine inhibits p53 tumor suppressor activity
-
Hudson JD, Shoaibi MA, Maestro R, Carnero A, Hannon GJ, Beach DH. A proinflammatory cytokine inhibits p53 tumor suppressor activity. J Exp Med. 1999;190:1375-82.
-
(1999)
J Exp Med
, vol.190
, pp. 1375-1382
-
-
Hudson, J.D.1
Shoaibi, M.A.2
Maestro, R.3
Carnero, A.4
Hannon, G.J.5
Beach, D.H.6
-
42
-
-
34547640039
-
Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity
-
Lue H, Thiele M, Franz J, Dahl E, Speckgens S, Leng L, et al. Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity. Oncogene. 2007;26:5046-59.
-
(2007)
Oncogene
, vol.26
, pp. 5046-5059
-
-
Lue, H.1
Thiele, M.2
Franz, J.3
Dahl, E.4
Speckgens, S.5
Leng, L.6
-
43
-
-
12444274813
-
Macrophage migration inhibitory factor MIF interferes with the Rb-E2F pathway
-
Petrenko O, Moll UM. Macrophage migration inhibitory factor MIF interferes with the Rb-E2F pathway. Mol Cell. 2005;17:225-36.
-
(2005)
Mol Cell
, vol.17
, pp. 225-236
-
-
Petrenko, O.1
Moll, U.M.2
-
44
-
-
33846435328
-
Amplification of tumor hypoxic responses by macrophage migration inhibitory factor-dependent hypoxia-inducible factor stabilization
-
Winner M, Koong AC, Rendon BE, Zundel W, Mitchell RA. Amplification of tumor hypoxic responses by macrophage migration inhibitory factor-dependent hypoxia-inducible factor stabilization. Cancer Res. 2007;67:186-93.
-
(2007)
Cancer Res
, vol.67
, pp. 186-193
-
-
Winner, M.1
Koong, A.C.2
Rendon, B.E.3
Zundel, W.4
Mitchell, R.A.5
-
45
-
-
77954614191
-
Macrophage migration inhibitory factor (MIF): a promising biomarker
-
Grieb G, Merk M, Bernhagen J, Bucala R. Macrophage migration inhibitory factor (MIF): a promising biomarker. Drug News Perspect. 2010;23:257-64.
-
(2010)
Drug News Perspect
, vol.23
, pp. 257-264
-
-
Grieb, G.1
Merk, M.2
Bernhagen, J.3
Bucala, R.4
-
46
-
-
79951605495
-
CD74: an emerging opportunity as a therapeutic target in cancer and autoimmune disease
-
Borghese F, Clanchy FI. CD74: an emerging opportunity as a therapeutic target in cancer and autoimmune disease. Expert Opin Ther Targets. 2011;15:237-51.
-
(2011)
Expert Opin Ther Targets
, vol.15
, pp. 237-251
-
-
Borghese, F.1
Clanchy, F.I.2
-
47
-
-
78650385895
-
Active immunotherapy induces antibody responses that target tumor angiogenesis
-
Schoenfeld J, Jinushi M, Nakazaki Y, Wiener D, Park J, Soiffer R, et al. Active immunotherapy induces antibody responses that target tumor angiogenesis. Cancer Res. 2010;70:10150-60.
-
(2010)
Cancer Res
, vol.70
, pp. 10150-10160
-
-
Schoenfeld, J.1
Jinushi, M.2
Nakazaki, Y.3
Wiener, D.4
Park, J.5
Soiffer, R.6
-
49
-
-
77953149880
-
Autocrine induction of invasive and metastatic phenotypes by the MIF-CXCR4 axis in drug-resistant human colon cancer cells
-
Dessein AF, Stechly L, Jonckheere N, Dumont P, Monte D, Leteurtre E, et al. Autocrine induction of invasive and metastatic phenotypes by the MIF-CXCR4 axis in drug-resistant human colon cancer cells. Cancer Res. 2010;70:4644-54.
-
(2010)
Cancer Res
, vol.70
, pp. 4644-4654
-
-
Dessein, A.F.1
Stechly, L.2
Jonckheere, N.3
Dumont, P.4
Monte, D.5
Leteurtre, E.6
-
50
-
-
33845418379
-
Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells
-
Meyer-Siegler KL, Iczkowski KA, Leng L, Bucala R, Vera PL. Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells. J Immunol. 2006;177:8730-9.
-
(2006)
J Immunol
, vol.177
, pp. 8730-8739
-
-
Meyer-Siegler, K.L.1
Iczkowski, K.A.2
Leng, L.3
Bucala, R.4
Vera, P.L.5
-
51
-
-
84875220714
-
Tumor-derived macrophage migration inhibitory factor promotes an autocrine loop that enhances renal cell carcinoma
-
Du W, Wright BM, Li X, Finke J, Rini BI, Zhou M, et al. Tumor-derived macrophage migration inhibitory factor promotes an autocrine loop that enhances renal cell carcinoma. Oncogene. 2013;32:1469-74.
-
(2013)
Oncogene
, vol.32
, pp. 1469-1474
-
-
Du, W.1
Wright, B.M.2
Li, X.3
Finke, J.4
Rini, B.I.5
Zhou, M.6
-
52
-
-
70450240780
-
The dexamethasone-induced inhibition of proliferation, migration, and invasion in glioma cell lines is antagonized by macrophage migration inhibitory factor (MIF) and can be enhanced by specific MIF inhibitors
-
Piette C, Deprez M, Roger T, Noel A, Foidart JM, Munaut C. The dexamethasone-induced inhibition of proliferation, migration, and invasion in glioma cell lines is antagonized by macrophage migration inhibitory factor (MIF) and can be enhanced by specific MIF inhibitors. J Biol Chem. 2009;284:32483-92.
-
(2009)
J Biol Chem
, vol.284
, pp. 32483-32492
-
-
Piette, C.1
Deprez, M.2
Roger, T.3
Noel, A.4
Foidart, J.M.5
Munaut, C.6
-
53
-
-
79952516379
-
Role of macrophage migration inhibitory factor in primary glioblastoma multiforme cells
-
Baron N, Deuster O, Noelker C, Stuer C, Strik H, Schaller C, et al. Role of macrophage migration inhibitory factor in primary glioblastoma multiforme cells. J Neurosci Res. 2011;89:711-7.
-
(2011)
J Neurosci Res
, vol.89
, pp. 711-717
-
-
Baron, N.1
Deuster, O.2
Noelker, C.3
Stuer, C.4
Strik, H.5
Schaller, C.6
-
54
-
-
84874971260
-
Overexpression of macrophage migration inhibitory factor in adenoid cystic carcinoma: correlation with enhanced metastatic potential
-
Liu H, Chen G, Zhang W, Zhu JY, Lin ZQ, Gong ZC, et al. Overexpression of macrophage migration inhibitory factor in adenoid cystic carcinoma: correlation with enhanced metastatic potential. J Cancer Res Clin Oncol. 2013;139:287-95.
-
(2013)
J Cancer Res Clin Oncol
, vol.139
, pp. 287-295
-
-
Liu, H.1
Chen, G.2
Zhang, W.3
Zhu, J.Y.4
Lin, Z.Q.5
Gong, Z.C.6
|